4.7 Article

Impact of Rome IV Irritable Bowel Syndrome on Work and Activities of Daily Living

期刊

ALIMENTARY PHARMACOLOGY & THERAPEUTICS
卷 56, 期 5, 页码 844-856

出版社

WILEY
DOI: 10.1111/apt.17132

关键词

absenteeism; activities of daily living; irritable bowel syndrome; presenteeism; work

资金

  1. Tillotts Pharma UK Ltd [RG.GASS.124592]

向作者/读者索取更多资源

This study aimed to analyze the impact of irritable bowel syndrome (IBS) on work and activities of daily living. The study found that patients experienced significant impairment in both work and various daily activities. Severe IBS, anxiety, depression, and other factors were associated with these impairments.
Background Few studies have demonstrated the impact of irritable bowel syndrome (IBS) on work and activities of daily living. Methods We collected demographic, gastrointestinal symptom, psychological health and quality of life data from 752 adults with Rome IV-defined IBS. We used the work productivity and activity impairment questionnaire for irritable bowel syndrome and the work and social adjustment scale to examine the degree of both impairment at work and in activities of daily living, as well as factors associated with these. Results Of 467 individuals who were employed, 133 (28.5%) reported absenteeism, 373 (85.6%) presenteeism and 382 (81.8%) overall work impairment. A mean of 1.97 hours of work per week was lost due to IBS. Extrapolating this across the entire UK, we estimate that between 72 and 188 million hours of work are lost per year due to IBS in individuals of working age. Among all 752 participants, 684 (91.0%) reported any activity impairment with 220 (29.3%) reporting impairment in home management, 423 (56.3%) in social leisure activities, 207 (27.5%) in private leisure activities, and 203 (27.0%) in maintaining close relationships. Severe IBS, higher levels of anxiety, depression, somatization and gastrointestinal symptom-specific anxiety, and lower levels of IBS-related quality of life were associated with impairment in both work and activities of daily living. Conclusion Patients with IBS experience a substantial impact on their work and activities of daily living because of their IBS. Future studies should assess the impact of medical interventions on the ability to work and participate in social activities.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Gastroenterology & Hepatology

Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials

Pierfrancesco Visaggi, Matteo Ghisa, Brigida Barberio, Daria Maniero, Eliana Greco, Vincenzo Savarino, Christopher J. Black, Alexander C. Ford, Nicola de Bortoli, Edoardo Savarino

Summary: This systematic review examines the research trends in the treatment of eosinophilic gastrointestinal diseases (EGIDs). The findings indicate that clinical trials primarily focus on corticosteroids and monoclonal antibodies. The therapeutic landscape of EGIDs is expected to undergo imminent transformation.

DIGESTIVE AND LIVER DISEASE (2023)

Review Gastroenterology & Hepatology

Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn's disease: systematic review and network meta-analysis

Brigida Barberio, David J. Gracie, Christopher J. Black, Alexander C. Ford

Summary: This study conducted a network meta-analysis to compare the relative efficacy of various biological therapies and small molecules in the treatment of luminal Crohn's disease. The results showed differences in the effectiveness of different drugs in inducing and maintaining clinical remission, and previous exposure to biologics also had an impact on treatment outcomes.
Article Gastroenterology & Hepatology

Characteristics and Effect of Anxiety and Depression Trajectories in Inflammatory Bowel Disease

Keeley M. Fairbrass, Elspeth A. Guthrie, Christopher J. Black, Christian P. Selinger, David J. Gracie, Alexander C. Ford

Summary: This study observed that symptoms of anxiety or depression in patients with inflammatory bowel disease (IBD) are associated with adverse clinical outcomes. The study reported on the trajectories of these symptoms, patient characteristics associated with different trajectories, and their effects on healthcare utilization and prognosis.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)

Review Gastroenterology & Hepatology

Response and Adverse Event Rates With Placebo in Gastroparesis: A Systematic Review and Meta-analysis

Journey L. Wise, Maria Rosa Ingrosso, Gianluca Ianiro, Christopher J. Black, Alexander C. Ford, Brian E. Lacy

Summary: This study systematically evaluated the therapeutic benefits of multiple drugs used to treat gastroparesis symptoms. The researchers found that the therapeutic benefits are poorly understood due to lack of insight into response and adverse event rates with placebo in randomized controlled trials. They also found that placebo response rates and adverse event rates varied among different types of gastroparesis patients and trial characteristics.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome

Vivek C. C. Goodoory, Elspeth A. A. Guthrie, Cho E. E. Ng, Christopher J. J. Black, Alexander C. C. Ford

Summary: Irritable bowel syndrome (IBS) has a substantial impact on the quality of life of affected individuals, and the negative impact is worse than observed in some severe chronic organic conditions.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

Impact of Baseline Disease Activity and Trial Duration on Efficacy of Biologics in Active Crohn's Disease: Meta-analysis

Brigida Barberio, David J. Gracie, Christopher J. Black, Alexander C. Ford

Summary: In this study, the authors conducted a systematic review and meta-analysis to evaluate the impact of criteria used to define CD activity at study entry and the time point used to confirm efficacy on the therapeutic gain of active drug over placebo. The results showed that both factors appeared to be important in maximizing the treatment effect of active drug compared to placebo.

INFLAMMATORY BOWEL DISEASES (2023)

Editorial Material Gastroenterology & Hepatology

Editorial: definition of factors associated with poor quality of life in patients with IBS-but where to from here? Authors' reply

Vivek C. Goodoory, Elspeth A. Guthrie, Cho Ee Ng, Christopher J. Black, Alexander C. Ford

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome

Vivek C. Goodoory, Cho E. Ng, Christopher J. Black, Alexander C. Ford

Summary: This study compared the characteristics of individuals with irritable bowel syndrome (IBS) reporting faecal incontinence (FI) with those who do not report FI. The results showed that individuals with FI were older, more likely to have IBS-D, had lower education levels and incomes, reported more urgency and more severe IBS and psychological symptoms, had lower quality of life scores, and higher healthcare costs.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

A prospective comparison of UK and Malaysian patients with irritable bowel syndrome in secondary care

Kee-Huat Chuah, Christopher J. Black, Vincent Tee, Sze-Zee Lim, Wen-Xuan Hian, Nur-Fazimah Sahran, Yeong-Yeh Lee, Sanjiv Mahadeva, Alexander C. Ford

Summary: By comparing IBS patients from the UK and Malaysia, it was found that UK patients were more likely to consume alcohol, had more frequent symptoms such as pain, bloating, and meal-related issues, higher symptom scores, greater limitation of activities, and a higher likelihood of reporting abnormal anxiety. UK patients also had higher levels of perceived stress, gastrointestinal symptom-specific anxiety, and somatoform symptom-reporting.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Editorial Material Gastroenterology & Hepatology

Editorial: faecal incontinence is prevalent in IBS, as are effective treatment options! Authors' reply

Vivek C. Goodoory, Cho Ee Ng, Christopher J. Black, Alexander C. Ford

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Review Gastroenterology & Hepatology

Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management

Heidi M. Staudacher, Christopher J. Black, Scott B. Teasdale, Antonina Mikocka-Walus, Laurie Keefer

Summary: Up to one-third of people with irritable bowel syndrome (IBS) also experience anxiety or depression. In this Review, we highlight common challenges that arise when managing patients with IBS and co-occurring anxiety and depression, and provide recommendations for tailoring clinical assessment and treatment.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Letter Gastroenterology & Hepatology

News from the Editors

Maura Corsetti, Frank Zerbib, Christopher Black, Andrea Shin, Kirsteen Browning, Fedias Chistofi, Daniel Keszthelyi

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

暂无数据